225 related articles for article (PubMed ID: 32568785)
1. Alzheimer Gene BIN1 may Simultaneously Influence Dementia Risk and Androgen Deprivation Therapy Dosage in Prostate Cancer.
Lehrer S; Rheinstein PH
Am J Clin Oncol; 2020 Oct; 43(10):685-689. PubMed ID: 32568785
[TBL] [Abstract][Full Text] [Related]
2. Co-occurrent Alterations of Alzheimer's Genes and Prostate Cancer Genes in Prostate Cancer.
Lehrer S; Rheinstein PH
Cancer Genomics Proteomics; 2020; 17(3):271-275. PubMed ID: 32345668
[TBL] [Abstract][Full Text] [Related]
3. Association Between Androgen Deprivation Therapy Use and Diagnosis of Dementia in Men With Prostate Cancer.
Jayadevappa R; Chhatre S; Malkowicz SB; Parikh RB; Guzzo T; Wein AJ
JAMA Netw Open; 2019 Jul; 2(7):e196562. PubMed ID: 31268539
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology.
Chapuis J; Hansmannel F; Gistelinck M; Mounier A; Van Cauwenberghe C; Kolen KV; Geller F; Sottejeau Y; Harold D; Dourlen P; Grenier-Boley B; Kamatani Y; Delepine B; Demiautte F; Zelenika D; Zommer N; Hamdane M; Bellenguez C; Dartigues JF; Hauw JJ; Letronne F; Ayral AM; Sleegers K; Schellens A; Broeck LV; Engelborghs S; De Deyn PP; Vandenberghe R; O'Donovan M; Owen M; Epelbaum J; Mercken M; Karran E; Bantscheff M; Drewes G; Joberty G; Campion D; Octave JN; Berr C; Lathrop M; Callaerts P; Mann D; Williams J; Buée L; Dewachter I; Van Broeckhoven C; Amouyel P; Moechars D; Dermaut B; Lambert JC;
Mol Psychiatry; 2013 Nov; 18(11):1225-34. PubMed ID: 23399914
[TBL] [Abstract][Full Text] [Related]
5. The Mechanistic Role of Bridging Integrator 1 (BIN1) in Alzheimer's Disease.
Gao P; Ye L; Cheng H; Li H
Cell Mol Neurobiol; 2021 Oct; 41(7):1431-1440. PubMed ID: 32719966
[TBL] [Abstract][Full Text] [Related]
6. Risk of Alzheimer's Disease Among Senior Medicare Beneficiaries Treated With Androgen Deprivation Therapy for Prostate Cancer.
Baik SH; Kury FSP; McDonald CJ
J Clin Oncol; 2017 Oct; 35(30):3401-3409. PubMed ID: 28841388
[TBL] [Abstract][Full Text] [Related]
7. Convergent lines of evidence support BIN1 as a risk gene of Alzheimer's disease.
Zhu J; Liu X; Yin H; Gao Y; Yu H
Hum Genomics; 2021 Jan; 15(1):9. PubMed ID: 33516273
[TBL] [Abstract][Full Text] [Related]
8. The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory.
Franzmeier N; Rubinski A; Neitzel J; Ewers M;
Nat Commun; 2019 Apr; 10(1):1766. PubMed ID: 30992433
[TBL] [Abstract][Full Text] [Related]
9. Clinical and genomic features of SPOP-mutant prostate cancer.
Nakazawa M; Fang M; H Marshall C; Lotan TL; Isaacsson Velho P; Antonarakis ES
Prostate; 2022 Feb; 82(2):260-268. PubMed ID: 34783071
[TBL] [Abstract][Full Text] [Related]
10. Androgen Deprivation Therapy Unrelated to Alzheimer's Disease in the UK Biobank Cohort.
Lehrer S; Rheinstein PH
Anticancer Res; 2023 Jan; 43(1):437-440. PubMed ID: 36585167
[TBL] [Abstract][Full Text] [Related]
11. BIN1 is decreased in sporadic but not familial Alzheimer's disease or in aging.
Glennon EB; Whitehouse IJ; Miners JS; Kehoe PG; Love S; Kellett KA; Hooper NM
PLoS One; 2013; 8(10):e78806. PubMed ID: 24205320
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease risk gene
Voskobiynyk Y; Roth JR; Cochran JN; Rush T; Carullo NV; Mesina JS; Waqas M; Vollmer RM; Day JJ; McMahon LL; Roberson ED
Elife; 2020 Jul; 9():. PubMed ID: 32657270
[TBL] [Abstract][Full Text] [Related]
13. Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate Cancer.
Yang DD; Mahal BA; Muralidhar V; Martin NE; Orio PF; Mouw KW; King MT; Choueiri TK; Trinh QD; Hoffman KE; Spratt DE; Feng FY; Nguyen PL
Eur Urol; 2019 Jan; 75(1):35-41. PubMed ID: 30554605
[TBL] [Abstract][Full Text] [Related]
14. Potential genetic biomarkers in the early diagnosis of Alzheimer disease: APOE and BIN1.
Kaya G; Gündüz E; Acar M; Hatipoğlu ÖF; Acar B; Ilhan A; Gündüz M
Turk J Med Sci; 2015; 45(5):1058-72. PubMed ID: 26738348
[TBL] [Abstract][Full Text] [Related]
15. Association Between Androgen Deprivation Therapy and Risk of Dementia.
Nead KT; Gaskin G; Chester C; Swisher-McClure S; Leeper NJ; Shah NH
JAMA Oncol; 2017 Jan; 3(1):49-55. PubMed ID: 27737437
[TBL] [Abstract][Full Text] [Related]
16. Subcellular Changes in Bridging Integrator 1 Protein Expression in the Cerebral Cortex During the Progression of Alzheimer Disease Pathology.
Adams SL; Tilton K; Kozubek JA; Seshadri S; Delalle I
J Neuropathol Exp Neurol; 2016 Aug; 75(8):779-790. PubMed ID: 27346750
[TBL] [Abstract][Full Text] [Related]
17. Predominant expression of Alzheimer's disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts.
De Rossi P; Buggia-Prévot V; Clayton BL; Vasquez JB; van Sanford C; Andrew RJ; Lesnick R; Botté A; Deyts C; Salem S; Rao E; Rice RC; Parent A; Kar S; Popko B; Pytel P; Estus S; Thinakaran G
Mol Neurodegener; 2016 Aug; 11(1):59. PubMed ID: 27488240
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity and tumor suppressor activity of Bin1 in prostate carcinoma.
Ge K; Minhas F; Duhadaway J; Mao NC; Wilson D; Buccafusca R; Sakamuro D; Nelson P; Malkowicz SB; Tomaszewski J; Prendergast GC
Int J Cancer; 2000 Apr; 86(2):155-61. PubMed ID: 10738240
[TBL] [Abstract][Full Text] [Related]
19. Potential contribution of the Alzheimer's disease risk locus BIN1 to episodic memory performance in cognitively normal Type 2 diabetes elderly.
Greenbaum L; Ravona-Springer R; Lubitz I; Schmeidler J; Cooper I; Sano M; Silverman JM; Heymann A; Beeri MS
Eur Neuropsychopharmacol; 2016 Apr; 26(4):787-95. PubMed ID: 26947052
[TBL] [Abstract][Full Text] [Related]
20. BIN1 in the Pursuit of Ousting the Alzheimer's Reign: Impact on Amyloid and Tau Neuropathology.
Kaur I; Behl T; Sundararajan G; Panneerselvam P; Vijayakumar AR; Senthilkumar GP; Venkatachalam T; Jaglan D; Yadav S; Anwer K; Fuloria NK; Sehgal A; Gulati M; Chigurupati S
Neurotox Res; 2023 Dec; 41(6):698-707. PubMed ID: 37847429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
